Skip to main content

Advertisement

Log in

Lidocaine controls pain and allows safe wound bed preparation and debridement of digital ulcers in systemic sclerosis: a retrospective study

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

In Systemic Sclerosis (SSc), digital ulcers (DU) are painful, difficult to heal, and frequently infected. To reduce the risk of bacterial infection and to prevent chronicity, it is essential to carefully remove necrotic tissue from DU, with maximum patient comfort. Debridement, although very efficacious, is invasive and causes local pain: lidocaine is a local anesthetic commonly used as to fight pain during debridement procedures. The aim of the study was to evaluate the efficacy of lidocaine 4 % in pain control during debridement procedure of DU in SSc. One hundred eight DU characterized by pain Numeric Rating Scale (NRS) >3/10 before starting the procedure were treated with lidocaine 4 % (lidocaine cloridrate 200 mg in 5 ml of injecting solution). Pain was measured with NRS (0–10) before starting debridement, after 15 min of lidocaine application and at the end of the procedure. In DU, in respect to baseline (mean NRS 6.74 ± 2.96), pain after application of lidocaine 4 % for 15 min was significantly lower (mean NRS 2.83 ± 2.73) (p < 0.001). At the end of the procedure, pain control was still maintained and significantly lower (mean NRS 2.88 ± 2.65) in respect to baseline (p < 0.001). No systemic adverse event due to topical lidocaine were observed. In SSc, topical application of lidocaine 4 % significantly reduces pain, allowing a safe debridement procedure, thus improving the management of DU.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Amanzi L, Braschi F, Fiori G, Galluccio F, Miniati I, Guiducci S et al (2010) Digital ulcers in scleroderma: staging, characteristics and subsetting through observation of 1614 digital lesion. Rheumatology (Oxford) 49:1374–1382

    Article  Google Scholar 

  2. Denton CP, Krieg T, Guillevin L, Schwierin B, Rosenberg D, Silkey M et al (2012) Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO registry. Ann Rheum Dis 71:718–721

    Article  PubMed  PubMed Central  Google Scholar 

  3. Matucci-Cerinic M, Krieg T, Guillevin L, Schwierin B, Rosenberg D, Cornelisse P, Denton CP. (2016) Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO Registry. Ann Rheum Dis 75(10):1770–1776

  4. European Wound Management Association (EWMA) (2004) Position document: wound bed preparation in practice. Medical Education Partnership Ltd, London

  5. Rosenthal D, Murphy F, Gottschalk R, Baxter M, Lycka B, Nevin K (2001) Using a topical anesthetic cream to reduce pain during sharp debridement of chronic leg ulcers. J Wound Care 10:503–505

    Article  CAS  PubMed  Google Scholar 

  6. Woo KY, Abbott LK, Librach L (2013) Evidence-based approach to manage persistent wound-related pain. Crr. Opin. Support. Palliat Care 7(1):86–94

    Google Scholar 

  7. Briggs M, Nelson EA, Martyn-St James M. (2012) Topical agents or dressing for pain in venous leg ulcers. Cochrane Database Syst Rev 11:CD001177

  8. Ozgocmen S, Kaya A, Coskun BK (2006) Topical lidocaine helps reduce pain of digital ulcers in systemic sclerosis (scleroderma. Clin Rheumatol 25(3):378–379

    Article  PubMed  Google Scholar 

  9. Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) Classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 72:1747–1755

    Article  PubMed  Google Scholar 

  10. Leroy EC, Black C, Fleishmajer R, Jablonska S, Krieg T, Medsger TA Jr et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francesca Bartoli.

Ethics declarations

Informed consent was obtained from all patients prior the procedure and the study was approved by our local ethical committee.

Disclosures

None.

Additional information

F. Braschi and Francesca Bartoli have contributed equally to this work

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Braschi, F., Bartoli, F., Bruni, C. et al. Lidocaine controls pain and allows safe wound bed preparation and debridement of digital ulcers in systemic sclerosis: a retrospective study. Clin Rheumatol 36, 209–212 (2017). https://doi.org/10.1007/s10067-016-3414-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-016-3414-7

Keywords

Navigation